NCT05183126 2026-03-06
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
University of Michigan Rogel Cancer Center
Phase 4 Recruiting
Clinical Trials
9 trialsNCT03096418 2026-01-16
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
University of Wisconsin, Madison
Phase 4 Recruiting
NCT02688803 2025-12-04
OTT15-04
Ottawa Hospital Research Institute
Phase 4 Terminated
NCT03355157 2024-10-01
PADMA
GBG Forschungs GmbH
Phase 4 Completed
NCT02419742 2022-10-12
Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen
Hoffmann-La Roche
Phase 4 Completed
NCT04031885 2021-08-24
A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer
Eli Lilly and Company
Phase 4 Terminated
NCT01094184 2018-03-22
BATMAN
Hoffmann-La Roche
Phase 4 Completed
NCT01156961 2016-11-02
A Study of The Safety Profile of First-line Avastin (Bevacizumab) in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Her2-negative Breast Cancer (AVATAX)
Hoffmann-La Roche
Phase 4 Withdrawn
NCT02207361 2015-12-22
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Unknown